Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001
- PMID: 12396914
- PMCID: PMC2730296
- DOI: 10.3201/eid0810.020329
Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001
Abstract
At least four Bacillus anthracis-containing envelopes destined for New York City and Washington, D.C. were processed at the Trenton Processing and Distribution Center (PDC) on September 18 and October 9, 2001. When cutaneous anthrax was confirmed in a Trenton postal worker, the PDC was closed. Four cutaneous and two inhalational anthrax cases were identified. Five patients were hospitalized; none died. Four were PDC employees; the others handled or received mail processed there. Onset dates occurred in two clusters following envelope processing at the PDC. The attack rate among the 170 employees present when the B. anthracis-containing letters were sorted on October 9 was 1.2%. Of 137 PDC environmental samples, 57 (42%) were positive. Five (10%) of 50 local post offices each yielded one positive sample. Cutaneous or inhalational anthrax developed in four postal employees at a facility where B. anthracis-containing letters were processed. Cross-contaminated mail or equipment was the likely source of infection in two other case-patients with cutaneous anthrax.
Figures


Similar articles
-
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.Emerg Infect Dis. 2002 Oct;8(10):1019-28. doi: 10.3201/eid0810.020353. Emerg Infect Dis. 2002. PMID: 12396909 Free PMC article.
-
Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.Emerg Infect Dis. 2002 Oct;8(10):1066-72. doi: 10.3201/eid0810.020330. Emerg Infect Dis. 2002. PMID: 12396917 Free PMC article.
-
Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001.Emerg Infect Dis. 2002 Oct;8(10):1073-7. doi: 10.3201/eid0810.020322. Emerg Infect Dis. 2002. PMID: 12396918 Free PMC article.
-
Recognition and management of anthrax--an update.N Engl J Med. 2001 Nov 29;345(22):1621-6. doi: 10.1056/NEJMra012892. Epub 2001 Nov 6. N Engl J Med. 2001. PMID: 11704686 Review. No abstract available.
-
When bioterrorism strikes: diagnosis and management of inhalational anthrax.Semin Respir Infect. 2003 Sep;18(3):134-45. Semin Respir Infect. 2003. PMID: 14505276 Review.
Cited by
-
Q fever outbreak in industrial setting.Emerg Infect Dis. 2004 Jul;10(7):1282-9. doi: 10.3201/eid1007.030536. Emerg Infect Dis. 2004. PMID: 15324550 Free PMC article.
-
The anthrax vaccine and research: reactions from postal workers and public health professionals.Biosecur Bioterror. 2008 Dec;6(4):321-33. doi: 10.1089/bsp.2007.0064. Biosecur Bioterror. 2008. PMID: 19117431 Free PMC article.
-
A Systematic Review of Risk Analysis Tools for Differentiating Unnatural From Natural Epidemics.Mil Med. 2017 Nov;182(11):e1827-e1835. doi: 10.7205/MILMED-D-17-00090. Mil Med. 2017. PMID: 29087849 Free PMC article.
-
Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis.Antimicrob Agents Chemother. 2008 Jul;52(7):2486-96. doi: 10.1128/AAC.01439-07. Epub 2008 May 5. Antimicrob Agents Chemother. 2008. PMID: 18458134 Free PMC article.
-
Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility.Infect Immun. 2004 Aug;72(8):4801-9. doi: 10.1128/IAI.72.8.4801-4809.2004. Infect Immun. 2004. PMID: 15271942 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Update: investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep. 2001;50:889–93. - PubMed
-
- Centers for Disease Control and Prevention. CDC case definition of anthrax and summary of confirmed cases. Available at: http://www.bt.cdc.gov/DocumentsApp/Anthrax/10212001PM.asp
-
- Greene CM, Pinner RW, Sejvar J, Dull P, Jernigan J, Stephens D, et al. Rapid adaptation of a serologic assay for the bioterrorism-related anthrax outbreak—October-December 2001. In: Abstracts of the International Conference on Emerging Infectious Diseases 2002; Atlanta, Georgia; 2002 Mar 24–27. Atlanta, Georgia: Centers for Disease Control and Prevention; 2002.
-
- Centers for Disease Control and Prevention. Procedures for collecting surface environmental samples for culturing Bacillus anthracis. Available at: http://www.bt.cdc.gov/DocumentsApp/Anthrax/11132001/Final42.asp
MeSH terms
LinkOut - more resources
Full Text Sources
Medical